Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.5850 (-3.52%) ($41.5100 - $41.5850) on Wed. Mar. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.96% (three month average) | RSI | 58 | Latest Price | $41.5850(-3.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.2% a day on average for past five trading days. | Weekly Trend | HALO advances 2.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(49%) IWM(47%) IWC(44%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.48% in a week (0% probabilities). VIXM(-30%) VXX(-12%) UUP(-12%) IGOV(-5%) GLD(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.48% (StdDev 2.96%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $43.39 | 5 Day Moving Average | $43.23(-3.81%) | 10 Day Moving Average | $43.6(-4.62%) | 20 Day Moving Average | $43.39(-4.16%) | To recent high | -20% | To recent low | 5.1% | Market Cap | $5.683b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |